CLINICAL_TRIALS
trial_result
· 2015-07-07
Clinical Trial Update: Rollover Study of VX-770 in Cystic Fibrosis Subjects [Phase 3]
Summary
Phase 3 rollover study of VX-770 (ivacaftor) in cystic fibrosis completed; results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2015-07-07